New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition | PLOS ONE
Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors | PLOS ONE
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection - ScienceDirect
Design of angiotensin converting enzyme inhibitors | Nature Medicine
New perspectives on angiotensin-converting enzyme 2 and its related diseases
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Benazepril hydrochloride, Angiotensin-converting enzyme (ACE) inhibitor (CAS 86541-74-4) (ab141166)
Angiotensin-Converting Enzyme - Proteopedia, life in 3D
Frontiers | Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2
Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension | Hypertension
Frontiers | Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension
CV Pharmacology | Angiotensin Converting Enzyme (ACE) Inhibitors
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | SpringerLink
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent | Hypertension
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers - BJA Education
Angiotensin‐converting enzyme as a new immunologic target for the new SARS‐CoV‐2 - Hallaj - 2021 - Immunology & Cell Biology - Wiley Online Library
IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
